Provided herein are methods of treating a
skin affliction, an ophthalmological affliction, or an
autoimmune disease comprising administering or applying to an individual having the
skin affliction an
active agent in a dosage sufficient to inactivate
demodex brevis and / or
demodex folliculorum mites from hair follicles and / or
skin of the individual, resulting in amelioration or cessation of the manifestations of allergic and / or
vasomotor responses to the mites that cause symptoms and signs of the affliction or
disease in the individual. Also provided herein are pharmaceutical formulations suitable for any of the methods.